NALM6 In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
CAT#: ITS-1122-YF4818
Target Cell Organism: Human
Target Cell Alternative Name: NALM-6
Target Cell Name: NALM6
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide NALM6-based In Vitro Protein Expression Analysis Assay (Immunoprecipitation) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NALM6
Target Cell Organism
Human
Target Cell Background
Nalm6 is a B cell precursor leukemia cell line initiated from an adolescent male. It is a CD24-positive xenograft model of acute lymphoblastic leukemia.
Target Cell Alternative Name
NALM-6
Related Diseases
Acute lymphoblastic leukemia; ALL
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
Short Description
NALM6-cell based In Vitro Protein Expression Analysis Assay (Immunoprecipitation)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.